首页 | 官方网站   微博 | 高级检索  
     

柚皮苷对人卵巢癌SKOV3细胞环氧化酶2mRNA及蛋白表达水平的影响
引用本文:宋淑慧,胡昕,熊玉卿,蔡丽萍.柚皮苷对人卵巢癌SKOV3细胞环氧化酶2mRNA及蛋白表达水平的影响[J].中国临床药理学与治疗学,2013,18(3):271-276.
作者姓名:宋淑慧  胡昕  熊玉卿  蔡丽萍
作者单位:1. 南昌大学第一附属医院妇产科,南昌330006,江西
2. 南昌大学医学院临床药理研究所,南昌330006,江西
基金项目:国家十二五科技重大专项"构建国际标准的规范化药物临床试验研究与评价技术平台"(项目编号:2011ZX09302-007-03)
摘    要:目的:研究中药柚皮苷对人卵巢癌SK—OV3细胞环氧化酶2(CoX-2)tuRNA及蛋白表达水平的影响。方法:常规培养人卵巢癌sK—OV3细胞,分为空白对照组、柚皮苷10umol/L组、柚皮苷20tzmol/L组、柚皮苷40umol/L组、阳性对照组(塞来昔布80tLmol/L)。MTT法测定柚皮苷对人卵巢癌SKOV3细胞增殖的影响,运用Real—timePCR和WesternBlot法测定培养48h后各组细胞中COX_2mRNA和蛋白表达水平的变化。结果:MTT检测法显示,柚皮苷各浓度处理组,时间依赖性和剂量依赖性地抑制人卵巢癌SKOV3细胞生长。经药物处理48h后,Real-timePCR结果显示,与空白对照组(1.094±0.053)比较,10、20umol/L柚皮苷即对SK—OV3细胞COX_2mRNA表达抑制作用(O.828±0.006,0.753±0.011,P〈0.05),而40gmol/L柚皮苷则明显下调COX-2mRNA的表达(0.412±0.216,P〈0.01),与塞来昔布组(0.321±0.017)的抑制程度相近。WesternBlot法检测结果显示,与空白对照组(1.7325±0.0826)相比,10umol/L柚皮苷组相对表达量(1.7925±0.0880)虽略有上调,但无统计学差异,20、40/umol/L柚皮苷组均可明显下调SKOV3细胞COX-2蛋白的表达(1.2225±0.0822,1.2725±0.0763,P〈0.05),塞来昔布组也明显抑制CoX-2蛋白的表达。结论:柚皮苷可抑制人卵巢癌SKOV3细胞体外增殖并抑制COX-2mRNA和蛋白的表达。

关 键 词:柚皮苷  环氧化酶2  人卵巢癌SKOV3细胞

Effects of Naringin on expression of COX-2 mRNA and protein in Human ovarian cancer cell line SKOV3
SONG Shu-hui,HU Xin.Effects of Naringin on expression of COX-2 mRNA and protein in Human ovarian cancer cell line SKOV3[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2013,18(3):271-276.
Authors:SONG Shu-hui  HU Xin
Affiliation:1 , XIONG Yu-qing2 , CAI Li-pingI Department of Gynecology and Obstetrics, the First Affiliated Hospital of Nanchang University Institute of Clinical Pharmacology, Medical College of Nanchang University, Nanchang 330006 Jiang3ci, China
Abstract:AIM: To investigate effects of na- ringin on expression of COX-2 mRNA and pro- tein of Human ovarian cancer cell line SKOV3. METHODS: SKOV3 cells were cultured in vitro and divided into five groups randomly, namelycontrol group, naringin group (10 /umol/L), na- ringin group (20 Ixmol/L), naringin group (40 umol/L) and celecoxib group (80/umol/L). The inhibition effects of naringin on cell- prolifera- tion were determined hy MTT method. The ex-pression of COX-2 mRNA and protein were eval- uated by Western Blot and Real-time quantita- tive PCR after forty-eight hours. RESULTS:Na- ringin could inhibit the growth of SKOV3 cells, and with the increase of the dosage and time, the tumor growth inhibition rate increased signifi- cantly ( P 〈 0.01 ). Compared with control group, the expression of COX-2 mRNA was down--regulated significantly by every dosage of naringin and celecoxib (0. 828±0. 006, 0. 753± 0. 011, while, 0.4124-0.216, 0.321±0.017). Mean the expression of COX-2 protein wasdown--regulated significantly by every dosage of naringin and celecoxib (1. 7925±0. 088, 1. 2225 ± 0.0822, 1.2725 ± 0.07632, 0.3075 ± 0.0977). CONCLUSION: The appropriate dos- age of naringin can inhibit SKOV3 cells growth in vitro, and can down-regulate the expression of COX-2 mRNA and protein.
Keywords:Naringin  COX-2  Human Ovar-ian cancer cell line SKOV3
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号